Xentuzumab (Anti-IGF-1)

Xentuzumab (Anti-IGF-1) is a recombinant a humanized monoclonal antibody that targets IGF ligands IGF-1 and IGF-2. Xentuzumab inhibits both of IGF-1 and IGF-2 growth-promoting signalling and suppresses AKT activation. MW: 145.5 KD.

Price Not Available 1mg Xentuzumab (Anti-IGF-1) Supplier Page
Trivial name BI 836845; Anti-Human IGF-1 and IGF-2 Recombinant Antibody
Catalog Number A2457
CAS# 1417158-65-6
Size 1mg
Supplier Page http://www.selleckchem.com/products/xentuzumab-anti-igf1.html